These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16224446)

  • 1. Review of 54-year-old man with breast cancer after prolonged testosterone therapy.
    Krause W
    Clin Adv Hematol Oncol; 2005 Sep; 3(9):714. PubMed ID: 16224446
    [No Abstract]   [Full Text] [Related]  

  • 2. 54-year-old man with breast cancer after prolonged testosterone therapy.
    Sorscher S
    Clin Adv Hematol Oncol; 2005 Sep; 3(9):713. PubMed ID: 16224445
    [No Abstract]   [Full Text] [Related]  

  • 3. 54-year-old man with breast cancer after prolonged testosterone therapy.
    Sorscher S; Krause W
    Clin Adv Hematol Oncol; 2005 Jun; 3(6):475; discussion 476. PubMed ID: 16167025
    [No Abstract]   [Full Text] [Related]  

  • 4. High risk of contralateral breast carcinoma in women with hereditary/familial non-BRCA1/BRCA2 breast carcinoma.
    Shahedi K; Emanuelsson M; Wiklund F; Gronberg H
    Cancer; 2006 Mar; 106(6):1237-42. PubMed ID: 16475207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Male Breast Cancer: A Study in Small Steps.
    Korde LA
    Oncologist; 2015 Jun; 20(6):584-5. PubMed ID: 25986243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of BRCA1 and BRCA2 mutation carrier prediction models in breast and/or ovarian cancer families of French Canadian descent.
    Oros KK; Ghadirian P; Maugard CM; Perret C; Paredes Y; Mes-Masson AM; Foulkes WD; Provencher D; Tonin PN
    Clin Genet; 2006 Oct; 70(4):320-9. PubMed ID: 16965326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.
    Uyei A; Peterson SK; Erlichman J; Broglio K; Yekell S; Schmeler K; Lu K; Meric-Bernstam F; Amos C; Strong L; Arun B
    Cancer; 2006 Dec; 107(12):2745-51. PubMed ID: 17109443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The case against BRCA 1 and 2 testing.
    Lin C; Sasaki T; Strumwasser A; Harken A
    Surgery; 2011 Jun; 149(6):731-4. PubMed ID: 21621683
    [No Abstract]   [Full Text] [Related]  

  • 9. The genetic epidemiology of male breast carcinoma.
    Lynch HT; Watson P; Narod SA
    Cancer; 1999 Sep; 86(5):744-6. PubMed ID: 10463967
    [No Abstract]   [Full Text] [Related]  

  • 10. Strictly defined familial male breast cancer.
    Güth U; Müller D; Huang DJ; Obermann E; Müller H
    Fam Cancer; 2011 Mar; 10(1):73-7. PubMed ID: 21061172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study.
    Eisen A; Lubinski J; Klijn J; Moller P; Lynch HT; Offit K; Weber B; Rebbeck T; Neuhausen SL; Ghadirian P; Foulkes WD; Gershoni-Baruch R; Friedman E; Rennert G; Wagner T; Isaacs C; Kim-Sing C; Ainsworth P; Sun P; Narod SA
    J Clin Oncol; 2005 Oct; 23(30):7491-6. PubMed ID: 16234515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous breast cancer in non-identical Ashkenazi Jewish twins: management dilemmas when genetic testing is negative.
    Sibtain A; Eeles R; Wellwood J; Plowman PN
    Clin Oncol (R Coll Radiol); 2000; 12(5):305-8. PubMed ID: 11315716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRCA1 and BRCA2: the genetic testing and the current management options for mutation carriers.
    Palma M; Ristori E; Ricevuto E; Giannini G; Gulino A
    Crit Rev Oncol Hematol; 2006 Jan; 57(1):1-23. PubMed ID: 16337408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families.
    Giannini G; Capalbo C; Ristori E; Ricevuto E; Sidoni T; Buffone A; Cortesi E; Marchetti P; Scambia G; Tomao S; Rinaldi C; Zani M; Ferraro S; Frati L; Screpanti I; Gulino A
    Breast Cancer Res Treat; 2006 Nov; 100(1):83-91. PubMed ID: 16847550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening-detected breast cancer in a man with BRCA2 mutation: case report.
    Brenner RJ; Weitzel JN; Hansen N; Boasberg P
    Radiology; 2004 Feb; 230(2):553-5. PubMed ID: 14752193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunolocalization of BRCA1 protein in tumor breast tissue: prescreening of BRCA1 mutation in Tunisian patients with hereditary breast cancer?
    Troudi W; Uhrhammer N; Ben Romdhane K; Sibille C; Mahfoudh W; Chouchane L; Ben Ayed F; Bignon YJ; Ben Ammar Elgaaied A
    Eur J Histochem; 2007; 51(3):219-26. PubMed ID: 17921118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer and long-term hormonal treatment of male hypogonadism.
    Medras M; Filus A; Jozkow P; Winowski J; Sicinska-Werner T
    Breast Cancer Res Treat; 2006 Apr; 96(3):263-5. PubMed ID: 16418796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mutational analysis of BRCA1 and BRCA2 genes in early-onset breast cancer patients in Shanghai].
    Song CG; Hu Z; Yuan WT; Di GH; Shen ZZ; Huang W; Shao ZM
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3030-4. PubMed ID: 16324400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRCA1 and BRCA2 germline mutations in Korean breast cancer patients at high risk of carrying mutations.
    Ahn SH; Son BH; Yoon KS; Noh DY; Han W; Kim SW; Lee ES; Park HL; Hong YJ; Choi JJ; Moon SY; Kim MJ; Kim KH; Kwak BS; Cho DY
    Cancer Lett; 2007 Jan; 245(1-2):90-5. PubMed ID: 16455195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the role of BRCA1, BRCA2 and RAD51 as biomarkers for breast cancer.
    Ziogas D; Liakakos T; Lykoudis E; Fatourou E; Roukos DH
    Radiother Oncol; 2009 Jan; 90(1):161-2. PubMed ID: 18343512
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.